Orphan designation: milademetan tosilate monohydrate Treatment of soft tissue sarcoma, 20/03/2017 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 23 October 2024 - 9:00

Orphan designation: milademetan tosilate monohydrate Treatment of soft tissue sarcoma, 20/03/2017 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-17-1847

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters